Loading organizations...
Loading organizations...
Science Exchange has raised $78.0M across 5 funding rounds.
Science Exchange was founded to address inefficiencies and a lack of quality control in scientific research outsourcing. It aimed to improve the quality and efficiency of scientific research by providing a centralized platform where R&D teams could harmonize purchasing and supplier management, thereby accelerating breakthrough discoveries.
Science Exchange operates a cloud-based R&D marketplace that serves as a platform for life sciences companies to buy and sell scientific services. Its core offering includes SaaS solutions for procurement and supplier management, allowing organizations to order and manage outsourced research and development services more efficiently.
The primary target customers for Science Exchange are life sciences companies and their R&D teams. These organizations leverage the platform to streamline their outsourced research and development needs, from harmonizing purchasing to comprehensive supplier management.
Science Exchange's mission is to significantly improve the quality and efficiency of scientific research globally. By making scientific research more accessible and manageable, the company aims to empower every organization on the planet to accelerate their research and development efforts.
A significant development in Science Exchange's corporate history was its acquisition by Waud Capital Partners. This acquisition indicates a new phase of growth and strategic direction, likely expanding its capabilities and market reach in life sciences procurement and supplier management.
Science Exchange was founded to address inefficiencies and a lack of quality control in scientific research outsourcing. It aimed to improve the quality and efficiency of scientific research by providing a centralized platform where R&D teams could harmonize purchasing and supplier management, thereby accelerating breakthrough discoveries.
Science Exchange operates a cloud-based R&D marketplace that serves as a platform for life sciences companies to buy and sell scientific services. Its core offering includes SaaS solutions for procurement and supplier management, allowing organizations to order and manage outsourced research and development services more efficiently.
The primary target customers for Science Exchange are life sciences companies and their R&D teams. These organizations leverage the platform to streamline their outsourced research and development needs, from harmonizing purchasing to comprehensive supplier management.
Science Exchange's mission is to significantly improve the quality and efficiency of scientific research globally. By making scientific research more accessible and manageable, the company aims to empower every organization on the planet to accelerate their research and development efforts.
A significant development in Science Exchange's corporate history was its acquisition by Waud Capital Partners. This acquisition indicates a new phase of growth and strategic direction, likely expanding its capabilities and market reach in life sciences procurement and supplier management.
Science Exchange provides a cloud-based R&D marketplace and supplier orchestration platform for life sciences companies. Its core product streamlines the entire outsourcing process, allowing organizations to discover, procure, and manage scientific services. The platform integrates solutions for procurement, compliance, and financial management, facilitating external research partnerships.
The company was founded in 2011 by Elizabeth Iorns, Ryan Abbott, and Dan Knox. Their insight arose from the fragmentation and inefficiencies in scientific research outsourcing, aiming to create a centralized ecosystem for R&D services. The founders sought to democratize access to specialized scientific capabilities, thereby accelerating discovery.
Science Exchange serves a range of life sciences organizations, assisting them with outsourced research requirements through its trusted platform. The company’s vision is to enhance the quality and efficiency of scientific research, making advanced R&D resources accessible and manageable for entities driving scientific innovation.
Science Exchange is a SaaS platform that streamlines and automates R&D outsourcing for leading life sciences companies by providing a digital marketplace and supplier orchestration system. It enables scientists to access a global network of over 3,800 pre-vetted suppliers, simplifying purchasing, supplier management, and payment processing in one integrated platform. This helps accelerate research programs by reducing manual administrative tasks and ensuring compliance, serving top pharmaceutical and biotech firms such as BMS, AbbVie, and Gilead[1][2].
Founded in 2011 and headquartered in Palo Alto, Science Exchange emerged from Y Combinator with a mission to democratize access to scientific resources and expertise. The company was co-founded by Elizabeth Iorns, who brought a scientific and entrepreneurial background to the venture. Early traction came from addressing the inefficiencies in R&D procurement and supplier collaboration, which resonated with large life sciences organizations seeking to accelerate innovation through streamlined outsourcing[1][3].
Science Exchange rides the growing trend of digital transformation in life sciences R&D, where outsourcing and collaboration with external labs and service providers are increasingly vital. The timing is favorable due to rising R&D costs, demand for faster drug development, and the need for flexible, scalable research partnerships. By automating and harmonizing supplier interactions, Science Exchange reduces bottlenecks and enables more agile innovation cycles. Its platform also supports the broader ecosystem by integrating with existing scientific tools and fostering a collaborative marketplace that benefits both buyers and suppliers[2][4].
Looking ahead, Science Exchange is poised to expand its clinical development solutions and scientific procurement capabilities, as evidenced by recent acquisitions and product announcements in 2025. Trends such as increased outsourcing in pharma R&D, adoption of digital procurement platforms, and demand for data-driven supplier management will likely shape its growth trajectory. The company’s influence may deepen as it continues to modernize R&D operations, potentially becoming the standard platform for scientific collaboration and supplier orchestration in life sciences[3][5].
In summary, Science Exchange transforms how life sciences companies access and manage outsourced research services, enabling scientists to focus on innovation while the platform handles the complexities of procurement and compliance. This positions it as a critical enabler in the evolving landscape of scientific research and development.
Science Exchange has raised $78.0M across 5 funding rounds. Most recently, it raised $20.0M Venture Round in October 2019.